Smart tablets based on halloysite nanotubes for controlled delivery and photoprotection of active pharmaceutical ingredients

A. Melnyk , G. Lazzara , O. Chyhyrynets
{"title":"Smart tablets based on halloysite nanotubes for controlled delivery and photoprotection of active pharmaceutical ingredients","authors":"A. Melnyk ,&nbsp;G. Lazzara ,&nbsp;O. Chyhyrynets","doi":"10.1016/j.hybadv.2025.100383","DOIUrl":null,"url":null,"abstract":"<div><div>The current direction of nanomedicine is the creation of smart systems for the controlled release of therapeutic drugs with simultaneous protection against photodegradation under the influence of UV and visible light. The aim of the investigation was to study the level of photoprotection and the kinetics of release of photosensitive pharmaceutical ingredients (α-lipoic acid and moxifloxacin hydrochloride) encapsulated in halloysite nanotubes in the composition of the tablets. It was established that halloysite, like the widely used microcrystalline cellulose, meets a sufficient level in terms of fluidity and compressibility, which indicates the possibility of its use as an auxiliary component in the composition of pharmaceutical tablet forms. The physical and mechanical properties (disintegration, hardness, friability and abrasion tests, tensile strength) of the obtained tablet based on halloysite (45 %), microcrystalline cellulose (50 %) and auxiliary components (5 %) indicate their compliance with the standardized requirements of the European Pharmacopoeia. In the native state, the ingredients are almost completely released from the tablets within the first 60 min. Encapsulation in halloysite promotes their controlled release from tablets within 24 h. With a change in the pH of the model medium from 1.2 to 6.8, the level of release and dissolution of both pharmaceutical ingredients increases. In 24 h, the release level reaches 60–80 % for α-lipoic acid and 42–75 % for moxifloxacin hydrochloride. It was found that encapsulation in halloysite contributes to an increase in the photostability of pharmaceutical ingredients. The reduction in the effective concentration of ingredients encapsulated in halloysite after the photostability test is no more than 2–5 %. Thus, halloysite can be used in smart tablet formulations as an effective nanocarrier to enhance photostability and control release of pharmaceutical ingredients.</div></div>","PeriodicalId":100614,"journal":{"name":"Hybrid Advances","volume":"9 ","pages":"Article 100383"},"PeriodicalIF":0.0000,"publicationDate":"2025-01-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Hybrid Advances","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2773207X25000077","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

The current direction of nanomedicine is the creation of smart systems for the controlled release of therapeutic drugs with simultaneous protection against photodegradation under the influence of UV and visible light. The aim of the investigation was to study the level of photoprotection and the kinetics of release of photosensitive pharmaceutical ingredients (α-lipoic acid and moxifloxacin hydrochloride) encapsulated in halloysite nanotubes in the composition of the tablets. It was established that halloysite, like the widely used microcrystalline cellulose, meets a sufficient level in terms of fluidity and compressibility, which indicates the possibility of its use as an auxiliary component in the composition of pharmaceutical tablet forms. The physical and mechanical properties (disintegration, hardness, friability and abrasion tests, tensile strength) of the obtained tablet based on halloysite (45 %), microcrystalline cellulose (50 %) and auxiliary components (5 %) indicate their compliance with the standardized requirements of the European Pharmacopoeia. In the native state, the ingredients are almost completely released from the tablets within the first 60 min. Encapsulation in halloysite promotes their controlled release from tablets within 24 h. With a change in the pH of the model medium from 1.2 to 6.8, the level of release and dissolution of both pharmaceutical ingredients increases. In 24 h, the release level reaches 60–80 % for α-lipoic acid and 42–75 % for moxifloxacin hydrochloride. It was found that encapsulation in halloysite contributes to an increase in the photostability of pharmaceutical ingredients. The reduction in the effective concentration of ingredients encapsulated in halloysite after the photostability test is no more than 2–5 %. Thus, halloysite can be used in smart tablet formulations as an effective nanocarrier to enhance photostability and control release of pharmaceutical ingredients.
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信